Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
Authors:
- R E ColemanRCR E Coleman
- M NicolsonMNM Nicolson
- W M GallmeierWGW M Gallmeier
- R C LeonardRLR C Leonard
- M A CornbleetMCM A Cornbleet
- S G AllanSAS G Allan
- B K UpadhyayaBUB K Upadhyaya
- U BruntschUBU Bruntsch
Open Access
Abstract
OBJECTIVE--To determine the contribution of dexamethasone to the efficacy of the 5-hydroxytryptamine antagonist ondansetron in control of cisplatin induced nausea and vomiting. DESIGN--Randomised double blind crossover study. SETTING--Two cancer centres in teaching hospitals, one in the United Kingdom and the other in Germany. SUBJECTS--100 patients (53 men and 47 women) new to cisplatin chemotherapy, 84 of whom completed two consecutive courses of chemotherapy. INTERVENTIONS--Patients were given intravenous dexamethasone (20 mg) or physiological saline with intravenous ondansetron 8 mg before cisplatin, then ondansetron 1 mg/h for 24 hours. Oral ondansetron 8 mg was taken three times daily on days 2-6. MAIN OUTCOME MEASURES--Incidence of complete or major control of emesis (0-2 episodes in the 24 hours after chemotherapy). RESULTS--Complete or major control was obtained in 49 out of 71 (69%) of patients after receiving ondansetron plus dexamethasone compared with 40 out of 71 (56%) when they were given ondansetron alone (p = 0.012). This effect was most pronounced in the first 12 hours after chemotherapy. Patients receiving the combination also had significantly less nausea. Of the 53 patients who expressed a preference, 38 (72%) preferred the combination treatment (p = 0.002) to ondansetron alone. The effect of ondansetron on delayed emesis was less pronounced. CONCLUSIONS--Dexamethasone makes a significant contribution to the efficacy of ondansetron in the control of acute platinum induced emesis.Keywords
This publication has 17 references indexed in Scilit:
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- ONDANSETRON WITH AND WITHOUT DEXAMETHASONE TO TREAT CHEMOTHERAPY-INDUCED EMESISThe Lancet, 1989
- Anti-emetic efficacy of dexamtheasone in combination for out-patients receiving cytotoxic chemotherapyCancer Chemotherapy and Pharmacology, 1986
- The use of methylprednisolone and metoclopramide in control of emesis in patients receiving cis-platinumGynecologic Oncology, 1985
- Emesis due to cancer chemotherapy: Results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomitingEuropean Journal of Cancer and Clinical Oncology, 1984
- Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.BMJ, 1984
- High-dose dexamethasone for prevention of cis-platin-induced vomitingCancer Chemotherapy and Pharmacology, 1981
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981
- The Comparison of Success Rates in Cross-Over Trials in the Presence of an Order EffectJournal of the Royal Statistical Society Series C: Applied Statistics, 1981
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979